Medicine Product Details




5 FEBRUARY

NEW ZEALAND GAZETTE

Product:

Infanrix-IPV+Hib

Component One:
Active Ingredients:

  • Pertactin 16µg/mL
  • Pertussis filamentous haemagglutinin 50µg/mL
  • Polio virus type 1 80DAgU/mL
  • Polio virus type 2 16DAgU/mL
  • Polio virus type 3 64DAgU/mL
  • Tetanus toxoid, adsorbed 80IU/mL

Dosage Form:
Suspension for injection

Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium

Component Two:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 20µg/mL

Dosage Form:
Powder for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium


Product:

Infanrix-IPV-Hib (Combination Product) (notification received 6 August 2003)

Component One:
Active Ingredients:

  • Detoxified pertussis toxin 50µg/mL
  • Diphtheria toxoid, adsorbed 60IU/mL
  • Pertactin 16µg/mL
  • Pertussis filamentous haemagglutinin 50µg/mL
  • Polio virus type 1 80DAgU/mL
  • Polio virus type 2 16DAgU/mL
  • Polio virus type 3 64DAgU/mL
  • Tetanus toxoid, adsorbed 80IU/mL

Dosage Form:
Suspension for injection

Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium

Component Two:
Active Ingredient:
Haemophilus influenzae vaccine, tetanus toxoid conjugate 20µg/mL

Dosage Form:
Powder for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium


Product:

Infanrix-penta

Active Ingredients:

  • Diphtheria toxoid, adsorbed 30IU/dose
  • Hepatitis B surface antigen, recombinant 10µg/dose
  • Pertactin 8µg/dose
  • Pertussis filamentous haemagglutinin 25µg/dose
  • Pertussis toxoid, adsorbed 25µg/dose
  • Polio virus type 1 40DAgU
  • Polio virus type 2 8DAgU
  • Polio virus type 3 32DAgU
  • Tetanus toxoid, adsorbed 40IU/dose

Dosage Form:
Suspension for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium


Product:

Mencevax ACWY vaccine

Active Ingredients:

  • Neisseria meningitidis, group A 50µg
  • Neisseria meningitidis, Group C 50µg
  • Neisseria meningitidis, group W135 50µg
  • Neisseria meningitidis, group Y 50µg

Dosage Form:
Powder for injection

New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited

Manufacturer:
GlaxoSmithKline Biologicals, Rixensart, Belgium


Product:

Provera HD

Active Ingredient:
Medroxyprogesterone acetate 100mg

Dosage Form:
Tablet

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Pharmacia Italia SpA, Marino del Tronto, Ascoli Piceno, Italy

269



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2004, No 11


Gazette.govt.nz PDF NZ Gazette 2004, No 11





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines (continued from previous page)

🏥 Health & Social Welfare
2 February 2004
Medicines Act 1981, Distribution, Changed Medicines, Infanrix-hexa, Infanrix-Hib, Infanrix-IPV, Infanrix-IPV-Hib

🏥 Product Details for Infanrix-IPV+Hib

🏥 Health & Social Welfare
Medicine, Vaccine, Product Details, GlaxoSmithKline, Infanrix-IPV+Hib

🏥 Product Details for Infanrix-IPV-Hib (Combination Product)

🏥 Health & Social Welfare
Medicine, Vaccine, Product Details, GlaxoSmithKline, Infanrix-IPV-Hib

🏥 Product Details for Infanrix-penta

🏥 Health & Social Welfare
Medicine, Vaccine, Product Details, GlaxoSmithKline, Infanrix-penta

🏥 Product Details for Mencevax ACWY vaccine

🏥 Health & Social Welfare
Medicine, Vaccine, Product Details, GlaxoSmithKline, Mencevax ACWY

🏥 Product Details for Provera HD

🏥 Health & Social Welfare
Medicine, Product Details, Pfizer, Provera HD